Hospice News November 2, 2022
As the dust settles from its divestiture of Kindred at Home’s hospice and personal care segments, Humana Inc. (NYSE: HUM) seeks to further expand into value-based care as both a provider and a payer.
Humana in August completed its $2.8 billion sale of a 60% stake in Kindred at Home’s hospice and personal care businesses to the private equity firm Clayton, Dubilier & Rice. Humana retained the remaining 40%.
The insurance company is applying the proceeds of the sale primarily to debt reduction, according to Humana CFO Susan Diamond. Humana has thus far cleared $2 billion of its debt following the divestiture, said Diamond.
“From a capital deployment perspective, our debt-to-capitalization ratio decreased by 590 basis points in the third...
Today's Sponsors
Today's Sponsor